Cargando…
Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells
To compare the drug-induced efficacies between omidenepag (OMD), an EP2 agonist, and prostaglandin F2α (PGF2α) on glaucomatous trabecular meshwork (TM) cells, two- and three-dimensional (2D and 3D) cultures of TGF-β2-modulated human trabecular meshwork (HTM) cells were used. The following analyses w...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954773/ https://www.ncbi.nlm.nih.gov/pubmed/35329980 http://dx.doi.org/10.3390/jcm11061652 |
_version_ | 1784676176161144832 |
---|---|
author | Suzuki, Soma Furuhashi, Masato Tsugeno, Yuri Umetsu, Araya Ida, Yosuke Hikage, Fumihito Ohguro, Hiroshi Watanabe, Megumi |
author_facet | Suzuki, Soma Furuhashi, Masato Tsugeno, Yuri Umetsu, Araya Ida, Yosuke Hikage, Fumihito Ohguro, Hiroshi Watanabe, Megumi |
author_sort | Suzuki, Soma |
collection | PubMed |
description | To compare the drug-induced efficacies between omidenepag (OMD), an EP2 agonist, and prostaglandin F2α (PGF2α) on glaucomatous trabecular meshwork (TM) cells, two- and three-dimensional (2D and 3D) cultures of TGF-β2-modulated human trabecular meshwork (HTM) cells were used. The following analyses were performed: (1) transendothelial electrical resistance (TEER) and FITC-dextran permeability measurements (2D), (2) the size and stiffness of the 3D spheroids, and (3) the expression (both 2D and 3D) by several extracellular matrix (ECM) molecules including collagen (COL) 1, 4 and 6, and fibronectin (FN), and α smooth muscle actin (αSMA), tight junction (TJ)-related molecules, claudin11 (Cldn11) and ZO1, the tissue inhibitor of metalloproteinase (TIMP) 1–4, matrix metalloproteinase (MMP) 2, 9 and 14, connective tissue growth factor (CTGF), and several endoplasmic reticulum (ER) stress-related factors. TGF-β2 significantly increased the TEER values and decreased FITC-dextran permeability, respectively, in the 2D HTM monolayers, and induced the formation of downsized and stiffer 3D HTM spheroids. TGF-β2-induced changes in TEER levels and FITC-dextran permeability were remarkably inhibited by PGF2α. PGF2α induced increases in the sizes and stiffness of the TGF-β2-treated 3D spheroids, but OMD enhanced only spheroid size. Upon exposure to TGF-β2, the expression of most of the molecules that were evaluated were significantly up-regulated, except some of ER stress-related factors were down-regulated. TJ-related molecules or ER stress-related factors were significantly up-regulated (2D) or down-regulated (3D), and down-regulated (2D) by PGF2α and OMD, while both drugs altered the expression of some of the other genes in the 3D spheroids in a different manner. The findings presented herein suggest that PGF2α and OMD differently modulate the permeability of the TGFβ2-modulated 2D monolayers and the physical properties of the 3D HTM spheroids. |
format | Online Article Text |
id | pubmed-8954773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89547732022-03-26 Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells Suzuki, Soma Furuhashi, Masato Tsugeno, Yuri Umetsu, Araya Ida, Yosuke Hikage, Fumihito Ohguro, Hiroshi Watanabe, Megumi J Clin Med Article To compare the drug-induced efficacies between omidenepag (OMD), an EP2 agonist, and prostaglandin F2α (PGF2α) on glaucomatous trabecular meshwork (TM) cells, two- and three-dimensional (2D and 3D) cultures of TGF-β2-modulated human trabecular meshwork (HTM) cells were used. The following analyses were performed: (1) transendothelial electrical resistance (TEER) and FITC-dextran permeability measurements (2D), (2) the size and stiffness of the 3D spheroids, and (3) the expression (both 2D and 3D) by several extracellular matrix (ECM) molecules including collagen (COL) 1, 4 and 6, and fibronectin (FN), and α smooth muscle actin (αSMA), tight junction (TJ)-related molecules, claudin11 (Cldn11) and ZO1, the tissue inhibitor of metalloproteinase (TIMP) 1–4, matrix metalloproteinase (MMP) 2, 9 and 14, connective tissue growth factor (CTGF), and several endoplasmic reticulum (ER) stress-related factors. TGF-β2 significantly increased the TEER values and decreased FITC-dextran permeability, respectively, in the 2D HTM monolayers, and induced the formation of downsized and stiffer 3D HTM spheroids. TGF-β2-induced changes in TEER levels and FITC-dextran permeability were remarkably inhibited by PGF2α. PGF2α induced increases in the sizes and stiffness of the TGF-β2-treated 3D spheroids, but OMD enhanced only spheroid size. Upon exposure to TGF-β2, the expression of most of the molecules that were evaluated were significantly up-regulated, except some of ER stress-related factors were down-regulated. TJ-related molecules or ER stress-related factors were significantly up-regulated (2D) or down-regulated (3D), and down-regulated (2D) by PGF2α and OMD, while both drugs altered the expression of some of the other genes in the 3D spheroids in a different manner. The findings presented herein suggest that PGF2α and OMD differently modulate the permeability of the TGFβ2-modulated 2D monolayers and the physical properties of the 3D HTM spheroids. MDPI 2022-03-16 /pmc/articles/PMC8954773/ /pubmed/35329980 http://dx.doi.org/10.3390/jcm11061652 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Suzuki, Soma Furuhashi, Masato Tsugeno, Yuri Umetsu, Araya Ida, Yosuke Hikage, Fumihito Ohguro, Hiroshi Watanabe, Megumi Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells |
title | Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells |
title_full | Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells |
title_fullStr | Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells |
title_full_unstemmed | Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells |
title_short | Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells |
title_sort | comparison of the drug-induced efficacies between omidenepag isopropyl, an ep2 agonist and pgf2α toward tgf-β2-modulated human trabecular meshwork (htm) cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954773/ https://www.ncbi.nlm.nih.gov/pubmed/35329980 http://dx.doi.org/10.3390/jcm11061652 |
work_keys_str_mv | AT suzukisoma comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells AT furuhashimasato comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells AT tsugenoyuri comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells AT umetsuaraya comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells AT idayosuke comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells AT hikagefumihito comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells AT ohgurohiroshi comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells AT watanabemegumi comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells |